Share on StockTwits

Sanofi SA (NYSE:SNY) saw a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 1,218,694 shares, a decrease of 47.8% from the July 15th total of 2,332,702 shares, AnalystRatingsNetwork.com reports. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 956,135 shares, the short-interest ratio is presently 1.3 days.

A number of research firms have recently commented on SNY. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Monday, August 4th. They now have a $56.00 price target on the stock. Analysts at Mainfirst upgraded shares of Sanofi SA to an “outperform” rating in a research note on Monday, July 28th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Sanofi SA currently has an average rating of “Hold” and a consensus price target of $54.50.

Shares of Sanofi SA (NYSE:SNY) opened at 53.29 on Wednesday. Sanofi SA has a 52-week low of $46.95 and a 52-week high of $54.64. The stock has a 50-day moving average of $52.20 and a 200-day moving average of $52.13. The company has a market cap of $139.8 billion and a price-to-earnings ratio of 25.71.

Sanofi SA (NYSE:SNY) last released its earnings data on Thursday, July 31st. The company reported $0.72 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.79 by $0.07. On average, analysts predict that Sanofi SA will post $3.50 earnings per share for the current fiscal year.

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.